GlassScriptPhysician profile
Brittany Jepson
NPI 1215025895
$5,332.93
in general payments reported to CMS, 2019-2025
35 companies · $1,750 in 2025
The $1,750 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $743 · 2023: $771 · 2024: $1,635 · 2025: $1,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,155.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,083.91 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,066.55 | 2022-2025 | |
| Pfizer INC. | $509.60 | 2021-2025 | |
| Lilly USA, LLC | $493.03 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $260.88 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $244.65 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $206.79 | 2024-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $138.26 | 2024-2025 | Voquezna |
| Amgen INC. | $124.06 | 2021-2022 | |
| Exact Sciences Corporation | $122.19 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.13 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.02 | 2021-2024 | Trintellix |
| Astellas Pharma US INC | $85.48 | 2023-2025 | Veozah, Myrbetriq |
| Biohaven Pharmaceutical Holding Company LTD. | $71.92 | 2022 | |
| Corcept Therapeutics | $70.56 | 2025 | Korlym |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Jepson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.